We found a match
Your institution may have access to this item. Find your institution then sign in to continue.
- Title
Perinatal outcome following third trimester exposure to paroxetine.
- Authors
Costei, Adriana Moldovan; Kozer, Eran; Ho, Tommy; Ito, Shinya; Koren, Gideon
- Abstract
Paroxetine hydrochloride is commonly used for maternal depression, panic disorder, and obsessive-compulsive disorder. The drug readily crosses the human placenta. Although it does not appear to increase teratogenic risk, there have been case reports of neonatal withdrawal. Symptoms were described soon after birth and lasted up to 1 month.
- Publication
Archives of pediatrics & adolescent medicine, 2002, Vol 156, Issue 11, p1129
- ISSN
1072-4710
- Publication type
Journal Article
- DOI
10.1001/archpedi.156.11.1129